About 2,753 results

ALLMedicine™ Kaposi Sarcoma Center

Research & Reviews  931 results

Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates.
PLoS Pathogens; Santiago JC, Adams SV et. al.

Nov 29th, 2022 - Kaposi sarcoma (KS), a common HIV-associated malignancy, presents a range of clinicopathological features. Kaposi sarcoma-associated herpesvirus (KSHV) is its etiologic agent, but the contribution of viral genomic variation to KS development is po...

Cutaneous Oncology in the Immunosuppressed.
Dermatologic Clinics; Wang LL, Lin SK et. al.

Nov 22nd, 2022 - Patients with immunosuppressive conditions experience an increased frequency and severity of cutaneous malignancies. This article highlights management of keratinocyte carcinoma, melanoma, Merkel cell carcinoma, and Kaposi sarcoma in the setting o...

Deconstructing the liquid architecture of human herpesvirus 8 diseases.
British Journal of Haematology; Polizzotto MN

Nov 19th, 2022 - Human herpesvirus 8 (HHV-8), also called Kaposi sarcoma herspesvirus (KSHV), causes several human tumours, which may be associated with systemic inflammation and body cavity effusions, including a form of multicentric Castleman disease (MCD) and a...

Ocular Kaposi Sarcoma Associated With Systemic Disease and Complete Resolution After Me...
JAMA Ophthalmology; Huang AM, Larochelle RD et. al.

Nov 18th, 2022 - Ocular Kaposi Sarcoma Associated With Systemic Disease and Complete Resolution After Medical Therapy.|2022|Huang AM,Larochelle RD,Hink EM,|diagnosis,drug therapy,

Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term us...
Journal of Medical Case Reports; Wu PJ, Sun CS et. al.

Nov 7th, 2022 - Kaposi sarcoma is a vascular tumor highly related to human herpesvirus-8 and Kaposi sarcoma-associated herpesvirus. Kaposi sarcoma usually manifests as skin or mucosal lesions; involvement in visceral organs such as the gastrointestinal tract is r...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  48 results

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Oct 14th, 2022 - PRIMARY OBJECTIVES: I. To determine the safety of combined nivolumab and cabozantinib s-malate (XL184 [cabozantinib]) in human immunodeficiency virus (HIV) patients with advanced solid tumors. II. To determine the feasibility to deliver the combin...

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Oct 14th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

History of the KSHV Inflammatory Cytokine Syndrome (KICS)

Oct 13th, 2022 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

A Study of sEphB4-HSA in Kaposi Sarcoma

Oct 13th, 2022 - sEphB4-HSA will be given through an intravenous infusion (into a vein). Each cycle of sEphB4-HSA will be 28 days (4 weeks). Each cycle of the study drug includes administration of 2 doses of sEphB4-HSA given on Days 1 and 15 of each cycle. Partici...

Pomalidomide Treatment in Patients With Kaposi Sarcoma

Oct 5th, 2022 - PRIMARY OBJECTIVE: I. To assess the proportion of participants with Kaposi sarcoma (KS) (with or without human immunodeficiency virus [HIV], regardless of previous treatment status) treated with pomalidomide who respond to treatment with a durable...

see more →

News  113 results

Lung Cancer Declining in People With HIV, but Still High

Oct 6th, 2022 - Lung cancer rates declined for people living with HIV but remained higher than the general population and, in older individuals, even higher than other cancers normally considered to be associated with HIV/AIDS, a population-based registry linkage...

Postirradiation Pseudosclerodermatous Panniculitis: A Rare Complication of Megavoltage External Beam Radiotherapy
Peter W. Hashim, MD, MHS, Nikki S. Vyas, MD et. al.

Jun 2nd, 2022 - To the Editor: Postirradiation pseudosclerodermatous panniculitis (PIPP) is a rarely reported complication of megavoltage external beam radiotherapy that was first identified in 1993 by Winkelmann et al. 1 The condition presents as an erythematous.

Leiomyosarcoma of the Penis: A Case Report and Re-Appraisal
Zainub Ajmal, MBBS, Abdul Moiz Khan, MBBS et. al.

May 16th, 2022 - Penile cancer is rare with a worldwide incidence of 0. 8 cases per 100,000 men.

Young Cancer Survivors Face Higher Risk of Death From Second Malignancies

May 4th, 2022 - Adolescent and young adult (AYA) cancer survivors have a significantly increased risk for developing a new cancer and dying from that cancer, according to a population-based study. These younger cancer survivors had a 25% higher risk for cancer in...

Indurated Violaceous Lesions on the Face, Trunk, and Legs
Yasmin Khalfe, MD, John Trace Worrell, MD et. al.

Feb 4th, 2022 - The Diagnosis: Kaposi Sarcoma A punch biopsy of a lesion on the right side of the back revealed a diffuse, poorly circumscribed, spindle cell neoplasm of the papillary and reticular dermis with associated vascular and pseudovascular spaces distend.

see more →

Patient Education  7 results see all →